Australian Gonococcal Surveillance Program, 1 January to 31 March 2026

Authors

  • Monica M Lahra NSW Health Pathology, The World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, Microbiology, The Prince of Wales Hospital, Randwick, NSW 2031, Australia; School of Medical Sciences, Faculty of Medicine, the University of New South Wales, Kensington, NSW 2052, Australia
  • Tiffany R Hogan NSW Health Pathology, The World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, Microbiology, The Prince of Wales Hospital, Randwick, NSW 2031, Australia

DOI:

https://doi.org/10.33321/cdi.2026.50.060

Keywords:

antimicrobial resistance, disease surveillance, gonococcal infection, Neisseria gonorrhoeae

Abstract

The Australian National Neisseria Network (NNN) comprises reference laboratories in each state and territory that report data on antimicrobial susceptibility testing to an agreed group of antimicrobial agents for the Australian Gonococcal Surveillance Programme (AGSP). The AGSP data are presented quarterly in tabulated form, as well as in the AGSP annual report. This report presents national gonococcal antimicrobial resistance surveillance data from 1 January to 31 March 2026.

Downloads

Download data is not yet available.

References

Northern Territory Government Department of Health (NT Health) Centre for Disease Control. Penicillinase-producing Neisseria gonorrhoeae (PPNG) and treatment recommendations for gonorrhoea. Darwin: NT Health; 11 March 2024. [Accessed on 11 July 2024.] Available from: https://health.nt.gov.au/__data/assets/pdf_file/0008/1356146/health-alert-ppng-240311.pdf.

World Health Organization (WHO). Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Geneva: WHO; 2012. Available from: https://apps.who.int/iris/handle/10665/44863.

Lahra MM, Hogan TR. Australian Gonococcal Surveillance Programme Annual Report, 2025. Commun Dis Intell (2018). 2026;50. doi: httos://doi.org/10.33321/cdi.2026.50.057.

van Hal SJ, Lahra MM, Whiley DM. Determining targets for ceftriaxone resistance detection in Neisseria gonorrhoeae based on genotype-phenotype data: an observational study. Lancet Microbe. 2025;6(11):101199. doi: https://doi.org/10.1016/j.lanmic.2025.101199.

van der Veen S, Sun X, Ge H, Chau TM, Nhung PH, Vandelannoote K et al. PenA alleles associated with gonococcal ceftriaxone resistance in Cambodia, China, and Vietnam. Clin Infect Dis. 2026;81(Suppl 5):S238–42. doi: https://doi.org/10.1093/cid/ciaf530.

Tapsall JW, Ndowa F, Lewis DA, Unemo M. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther. 2009;7(7):821–34. doi: https://doi.org/10.1586/eri.09.63.

van Hal SJ, Sherry N, Coombs G, Mowlaboccus S, Whiley DM, Lahra MM. Emergence of an extensively drug-resistant Neisseria gonorrhoeae clone. Lancet Infect Dis. 2024;24(9):e547–8. doi: https://doi.org/10.1016/S1473-3099(24)00486-9.

Lahra MM, van Hal S, Hogan TR. Australian Gonococcal Surveillance Programme Annual Report, 2024. Commun Dis Intell (2018). 2025:49. doi: https://doi.org/10.33321/cdi.2025.49.056.

Ong JJ, Bourne C, Dean JA, Ryder N, Cornelisse VJ, Murray S et al. Australian sexually transmitted infection (STI) management guidelines for use in primary care, 2022 update. Sexual Health. 2023;20(1):1-8. doi: https://doi.org/10.1071/SH22134.

Light blue curved shape with the words Communicable Diseases Intelligence in dark blue. The bottom of the cover features dark blue and light blue shapes with a lockup of the logo of the Australian Centre for Disease Control alongside the Commonwealth Coat of Arms.

Downloads

Published

20/10/26

How to Cite

Lahra, Monica, and Tiffany Hogan. 2026. “Australian Gonococcal Surveillance Program, 1 January to 31 March 2026”. Communicable Diseases Intelligence 50 (October). https://doi.org/10.33321/cdi.2026.50.060.

Issue

Vol. 50 (2026)

Section

Recently published

Categories

License

Copyright (c) 2026 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.